(1)
CAR T-Cell Therapy Outcomes and Toxicity Profiles in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. ALR 2025, 6 (1), 10-15. https://doi.org/10.5281/zenodo.22238163.